← Leaderboards
Carol D Blair
Colorado State University-Fort Collins
$7,724,005
Attributed
$8,191,699
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $825.9K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,191,699 · 8
By mechanism
U54$5,966,531 · 4
R01$1,289,779 · 1
R44$493,407 · 1
R43$441,982 · 2
Top collaborators
- Donald L. Jarvis3 shared
Most similar at Colorado State University-Fort Collins
Same institution · by research overlap
- Kenneth E Olson$11,144,657
- Richard A Slayden$5,954,059
- Brian David Foy$8,995,321
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenViralVaccinesBiodefenseCategoriesCellsBaseAntibodiesLaboratoriesVirusAntibody RepertoireTransfection /Expression VectorVaccinationPan GenusHuman Monoclonal AntibodiesMonoclonal AntibodiesResearch PersonnelDengueGene ExpressionGene MutationAntiviral AgentsCareerCommunicable Disease TransmissionFunding
Grant awards (27)
Insect cell lines for glycoprotein structural biology and mannose-dependent protein drugs$224,597
R43 · FY2020 · GM · contact PI
Engineering a new insect cell line for human-type protein glycosylation$217,385
R43 · FY2018 · GM · contact PI
Glycoengineered insect cells for commercial biologics manufacturing$493,407
R44 · FY2017 · GM · contact PI
Individual Career Development Support Program$589,155
U54 · FY2013 · AI · contact PI
Human monoclonal antibodies (huMAbs) for medically important arboviruses$228,669
U54 · FY2013 · AI · contact PI
Individual Career Development Support Program$608,202
U54 · FY2012 · AI · contact PI
Human monoclonal antibodies (huMAbs) for medically important arboviruses$217,735
U54 · FY2012 · AI · contact PI
Individual Career Development Support Program$578,327
U54 · FY2011 · AI · contact PI
Human monoclonal antibodies (huMAbs) for medically important arboviruses$221,617
U54 · FY2011 · AI · contact PI
Individual Career Development Support Program$568,699
U54 · FY2010 · AI · contact PI
Human monoclonal antibodies (huMAbs) for medically important arboviruses$248,450
U54 · FY2010 · AI · contact PI
Individual Career Development Support Program$492,803
U54 · FY2009 · AI · contact PI
Human monoclonal antibodies (huMAbs) for medically important arboviruses$214,888
U54 · FY2009 · AI · contact PI
Human Monoclonal Antibodies for VEE Virus$255,061
U54 · FY2008 · AI · contact PI
Human Monoclonal Antibodies for VEE Virus$365,673
U54 · FY2007 · AI · contact PI
Specialized Biodefense Training in Basic Research$337,247
U54 · FY2007 · AI · contact PI
Human Monoclonal Antibodies for VEE Virus$272,201
U54 · FY2006 · AI · contact PI
Specialized Biodefense Training in Basic Research$250,422
U54 · FY2006 · AI · contact PI
Interference to Dengue Virus Replication in Mosquitoes$210,876
R01 · FY2006 · AI · contact PI
Human Monoclonal Antibodies for VEE Virus$269,286
U54 · FY2005 · AI
Specialized Biodefense Training in Basic Research$248,096
U54 · FY2005 · AI
Interference to Dengue Virus Replication in Mosquitoes$215,996
R01 · FY2005 · AI
Interference to Dengue Virus Replication in Mosquitoes$216,040
R01 · FY2004 · AI
Interference to Dengue Virus Replication in Mosquitoes$216,083
R01 · FY2003 · AI
Interference to Dengue Virus Replication in Mosquitoes$120,562
R01 · FY2002 · AI
INTERFERENCE TO DENGUE VIRUS REPLICATION IN MOSQUITOES$157,403
R01 · FY2001 · AI
INTERFERENCE TO DENGUE VIRUS REPLICATION IN MOSQUITOES$152,819
R01 · FY2000 · AI